Evaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal

Abstract

BackgroundHIV infection is a concern in the army troupes because of the risk behaviour of the military population. In order to allow regular access to CD4+ T cell enumeration of military personnel as well as their dependents and civilians living with HIV, the Senegalese Army AIDS program is implementing PIMATM Alere technology in urban and semi-urban military medical centres. Validation such device is therefore required prior their wide implementation. The purpose of this study was to compare CD4+ T cell count measurements between the PIMATM Alere to the BD FACSCountTM.MethodologyWe selected a total of 200 subjects including 50 patients with CD4+ T-cells below 200/mm3, 50 between 200 and 350/mm3, 50 between 351 and 500/mm3, and 50 above 500/mm3. CD4+ T-cell count was performed on venous blood using the BD FASCountTM as reference method and the PIMATM Point of Care technology. The mean biases and limits of agreement between the PIMATM Alere and BD FACSCountTM were assessed with the Bland-Altman analysis, the linear regression performed using the Passing-Bablok regression analysis, and the percent similarity calculated using the Scott method.ResultsOur data have shown a mean difference of 22.3 cells/mm3 [95%CI:9.1–35.5] between the BD FACSCountTM and PIMATM Alere CD4 measurements. However, the mean differences of the two methods was not significantly different to zero when CD4+ T-cell count was below 350/mm3 (P = 0.76). The Passing-Bablok regression in categorized CD4 counts has also showed concordance correlation coefficient of 0.89 for CD4+ T cell counts below 350/mm3 whilst it was 0.5 when CD4 was above 350/mm3.ConclusionOverall, our data have shown that for low CD4 counts, the results from the PIMATM Alere provided accurate CD4+ T cell counts with a good agreement compared to the FACSCountTM.

Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study

“…Considering the limited laboratory facilities in Sierra Leone, diagnostic services and technical expertise should be scaled up to facilitate universal screening, guide clinical decision-making and monitor treatment response. The use of point-of-care technology for CD4 enumeration and dried blood spots for HIV viral load monitoring and HBV DNA quantification have been validated in resource-limited settings and could play a vital role in optimizing linkage to and retention in care and improving clinical outcomes (WHO, 2015a;Desai et al, 2017;Faye et al, 2016;Vinikoor et al, 2015;Bargain et al, 2020).…”

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study

“…The fourth-generation rapid test by SD Bioline HIV-1/2 3.0 (Standard Diagnostics Inc) was used for HIV testing. CD4 cell count was determined using the Alere Pima™ Analyzer (Abbott), a point-of-care testing platform with comparable performance to flow cytometry-based methods and validated in resource-limited settings [9]. Tuberculosis was confirmed using the GeneXpert MTB/RIF assay (Cepheid) and/or sputum acid fast bacilli (AFB) smear, with compatible chest radiographic findings.…”

High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone

“…The Alere Pima Analyzer (Abbott) was used for CD4 enumeration. This is a well validated point-of-care CD4 testing platform with proven comparable performance to flow cytometry-based methods, especially in resource-limited settings [ 13 ]. The GeneXpert MTB/RIF assay (Cepheid) and sputum AFB smear with/without chest radiography was used to determine tuberculosis positive status.…”